Microcyn Gel Approved For Seborrheic Dermatitis
So it appears Oculus Innovative Sciences Inc. which is a specialty pharmaceutical company has received clearance to market a new Microcyn gel to treat seborrheic dermatitis. OISI creates and tests treatments for dermatological problems. The announcement coincides with a 510(k) approval from the U.S. Food and Drug Administration. It appears the company’s new product is a Microcyn-based gel aimed to treat associated symptoms of seborrheic dermatitis. This targets dry and waxy skin by creating a moist wound, in turn creating an ideal environment to improve healing process.
Oculus Innovative Sciences plans to partner with key distributors to provide this product worldwide. The United States expects to commercialize the gel sometime around June of 2016. President of IntraDerm Pharmaceuticals states “Our new Microcyn-based SebDerm gel adds a valuable tool to the dermaologist’s bag when it comes to combatting both seborrhea and seborrheic dermatitis”.
Statistics show almost a quarter of the worldwide population suffers with seborrheic dermatitis. This has spurned on research to tackle this incurable condition. People have been looking for a permanent solution and while this approval is one step in the right direction, we still have a long way to go to finding a permanent cure.
Microcyn Gel Technology
Hypochlorous acid is found in Microcyn Technology which has shown to kill bacteria and fungi. The denaturation process changes the structure of surface proteins of the microorganisms permanently. The concluding effect spells disaster for the pathogen as it’s destroyed. It’s important to note, Hypochlorous acid stops the microbes from spreading or even worse becoming resistant. The Microcyn gel in a way mimics the body’s natural reaction to unwanted microorganisms without any trouble at all.
Who is IntraDerm Pharmaceuticals?
This is simply a division of Oculus Innovative Sciences. IntraDerm Pharmaceuticals is a dermatological company using primarily Microcyn gel skin products. Their headquarters are located in Petaluma, California. They also have other divisions in the Netherlands as well as manufacturing bases in the U.S. and Latin America.
Who is Oculus Innovative Sciences Incorporated?
OISI is a pharmaceutical company that develops common solutions for the dermatological market. Many of the products from the company are sold in the United States and internationally. They’ve creative these solutions to help more than 5 million patients worldwide. A large part of their research goes into finding ways to reduce itching, infections, scarring and inflammation.